Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms
Condition(s):Quality of Life; Menopausal Syndrome; Libido DisorderLast Updated:March 16, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Quality of Life; Menopausal Syndrome; Libido DisorderLast Updated:March 16, 2016Completed
Condition(s):Vaginal AtrophyLast Updated:April 7, 2017Completed
Condition(s):Dehydroepiandrosterone; DHEAS; Gene Expression of Cumulus Cells.; Ovarian Hyper-stimulation Protocol.; Artificial Reproduction Technology.Last Updated:May 29, 2014Completed
Condition(s):InfertilityLast Updated:May 7, 2014Completed
Condition(s):DyspareuniaLast Updated:June 9, 2022Completed
Condition(s):Vasomotor Symptoms; Hot FlushesLast Updated:December 11, 2013Completed
Condition(s):Synovial Sarcoma; Sarcoma, SynovialLast Updated:September 9, 2019Terminated
Condition(s):Metastatic Breastcancer; Estrogen Receptor Positive Breast Cancer; Estrogen Receptor Negative Neoplasm; Progesterone Receptor Positive Tumor; Progesterone Receptor Negative Neoplasm; Androgen Receptor Gene OverexpressionLast Updated:September 29, 2016Terminated
Condition(s):Vaginal Atrophy in Breast Cancer PatientsLast Updated:July 31, 2020Withdrawn
Condition(s):Poor Responders; DehydroepiandrosteroneLast Updated:February 18, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.